|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
KETOCONAZOLE MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
KETOCONAZOLE MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
KETOCONAZOLE MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
ITRACONAZOLE REDUCES THE DRUG METABOLISM HENCE SERUM LEVELS ARE INCREASED
|
ERYTHROMYCIN INCREASES PLASMA CONCENTRATION OF THE DRUG DUE TO REDUCED CLEARANCE
|
ERYTHROMYCIN INCREASES PLASMA CONCENTRATION OF THE DRUG DUE TO REDUCED CLEARANCE
|
ERYTHROMYCIN INCREASES PLASMA CONCENTRATION OF THE DRUG DUE TO REDUCED CLEARANCE
|
ERYTHROMYCIN INCREASES PLASMA CONCENTRATION OF THE DRUG DUE TO REDUCED CLEARANCE
|
ERYTHROMYCIN INCREASES PLASMA CONCENTRATION OF THE DRUG DUE TO REDUCED CLEARANCE
|
INCREASED HYPOTENSIVE EFFECT IS SEEN OR DEATH DUE TO SOME POSSIBLE INTERACTION
|
INCREASED HYPOTENSIVE EFFECT IS SEEN OR DEATH DUE TO SOME POSSIBLE INTERACTION
|
INCREASED HYPOTENSIVE EFFECT IS SEEN OR DEATH DUE TO SOME POSSIBLE INTERACTION
|
INCREASED HYPOTENSIVE EFFECT IS SEEN OR DEATH DUE TO SOME POSSIBLE INTERACTION
|
INCREASED HYPOTENSIVE EFFECT IS SEEN OR DEATH DUE TO SOME POSSIBLE INTERACTION
|
INCREASED HYPOTENSIVE EFFECT IS SEEN OR DEATH DUE TO SOME POSSIBLE INTERACTION
|
INCREASED HYPOTENSIVE EFFECT IS SEEN OR DEATH DUE TO SOME POSSIBLE INTERACTION
|
SAQUINAVIR COMPETES FOR CYP3A ENZYME RESULTING IN IHBITION OF METABOLISM OF OTHER DRUG & INCREASED PLASMA LEVELS
|
LOPINAVIR INCREASES ITS PLASMA LEVELS
|